it will probably be cheaper to get approval in Europe than going for rosacea or MRSA to gain more revenue but I'm here for the long term so as long as they are still moving forward I'm happy
Ann: March 2023 Quarterly Activities Report and Appendix 4C, page-33
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $671.1M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 37.0¢ | $1.232M | 3.263M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 21 | 413183 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 50000 | 1 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |